DUBLIN--(BUSINESS WIRE)--The "Albumin - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Amid the COVID-19 crisis, the global market for Albumin estimated at US$808 Million in the year 2020, is projected to reach a revised size of US$1 Billion by 2027, growing at a CAGR of 3.4% over the period 2020-2027.Human Serum Albumin, one of the segments analyzed in the report, is projected to grow at a 3.1% CAGR to reach US$801.3 Million by the end of the analysis period.
After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Recombinant Albumin segment is readjusted to a revised 4.7% CAGR for the next 7-year period. This segment currently accounts for a 20.1% share of the global Albumin market.
The U.S. Accounts for Over 27% of Global Market Size in 2020, While China is Forecast to Grow at a 6.3% CAGR for the Period of 2020-2027
The Albumin market in the U.S. is estimated at US$218.2 Million in the year 2020. The country currently accounts for a 27% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$212.8 Million in the year 2027 trailing a CAGR of 6.2% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1% and 2.6% respectively over the 2020-2027 period.
Within Europe, Germany is forecast to grow at approximately 1.7% CAGR while Rest of European market (as defined in the study) will reach US$212.8 Million by the year 2027. We bring years of research experience to this 8th edition of our report. The 275-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others
- Albumedix Ltd.
- Albumin Bioscience
- Biotest AG
- CSL Behring
- Grifols International SA
- HiMedia Laboratories Pvt. Ltd.
- InVitria
- Medxbio Pte. Ltd.
- MilliporeSigma
- Octapharma AG
- RayBiotech, Inc.
-
Seracare Life Sciences, Inc.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Global Competitor Market Shares
- Albumin Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
-
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
Total Companies Profiled: 41
For more information about this report visit https://www.researchandmarkets.com/r/uia0g5
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900